SG10201502661SA - T cell epitope databases - Google Patents

T cell epitope databases

Info

Publication number
SG10201502661SA
SG10201502661SA SG10201502661SA SG10201502661SA SG10201502661SA SG 10201502661S A SG10201502661S A SG 10201502661SA SG 10201502661S A SG10201502661S A SG 10201502661SA SG 10201502661S A SG10201502661S A SG 10201502661SA SG 10201502661S A SG10201502661S A SG 10201502661SA
Authority
SG
Singapore
Prior art keywords
cell epitope
epitope databases
databases
cell
epitope
Prior art date
Application number
SG10201502661SA
Other languages
English (en)
Inventor
Frank Carr
Matthew Paul Baker
Original Assignee
Antitope Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0620123A external-priority patent/GB0620123D0/en
Priority claimed from GB0620129A external-priority patent/GB0620129D0/en
Application filed by Antitope Ltd filed Critical Antitope Ltd
Publication of SG10201502661SA publication Critical patent/SG10201502661SA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/10—Ontologies; Annotations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Chemical & Material Sciences (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Databases & Information Systems (AREA)
  • Bioethics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG10201502661SA 2006-10-11 2007-10-11 T cell epitope databases SG10201502661SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0620123A GB0620123D0 (en) 2006-10-11 2006-10-11 T cell assays
GB0620129A GB0620129D0 (en) 2006-10-11 2006-10-11 T cell epitope databases

Publications (1)

Publication Number Publication Date
SG10201502661SA true SG10201502661SA (en) 2015-05-28

Family

ID=39156427

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201502661SA SG10201502661SA (en) 2006-10-11 2007-10-11 T cell epitope databases
SG2011072956A SG175596A1 (en) 2006-10-11 2007-10-11 T cell epitope databases

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2011072956A SG175596A1 (en) 2006-10-11 2007-10-11 T cell epitope databases

Country Status (9)

Country Link
US (2) US20100017370A1 (ru)
EP (1) EP2080138A2 (ru)
JP (1) JP5456477B2 (ru)
KR (1) KR101485202B1 (ru)
AU (1) AU2007306102B2 (ru)
CA (1) CA2666320A1 (ru)
RU (1) RU2009113455A (ru)
SG (2) SG10201502661SA (ru)
WO (1) WO2008044032A2 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101814408B1 (ko) 2008-09-26 2018-01-04 다나-파버 캔서 인스티튜트 인크. 인간 항-ｐｄ-１, ｐｄ-ｌ１, 및 ｐｄ-ｌ2 항체 및 그의 용도
CA2775720A1 (en) 2009-09-30 2011-04-07 Saint Louis University Peptides for inducing heterosubtypic influenza t cell responses
GB201103955D0 (en) 2011-03-09 2011-04-20 Antitope Ltd Antibodies
BR112014013086A2 (pt) 2011-11-29 2020-10-27 Neurophage Pharmaceuticals, Inc. Composições para tratamento de doença associada com proteína amiloide agregada epara detectar ou gerar imagem de amiloide agregada e uso das referidas composições
US10000567B2 (en) 2012-06-14 2018-06-19 Therapix Biosciences Ltd. Humanized antibodies to cluster of differentiation 3 (CD3)
MX358755B (es) 2012-10-02 2018-09-03 Proclara Biosciences Inc Uso del p3 de proteinas de fusion de bacteriofago como agentes de union amiloides.
US9499855B2 (en) 2013-03-14 2016-11-22 Elwha Llc Compositions, methods, and computer systems related to making and administering modified T cells
US9587237B2 (en) 2013-03-14 2017-03-07 Elwha Llc Compositions, methods, and computer systems related to making and administering modified T cells
EP2971288A4 (en) * 2013-03-14 2016-12-07 Elwha Llc COMPOSITIONS, METHODS, AND COMPUTER SYSTEMS ASSOCIATED WITH THE PRODUCTION AND ADMINISTRATION OF MODIFIED T CELLS
SG11201509647WA (en) 2013-05-28 2015-12-30 Neurophage Pharmaceuticals Inc Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced immunogenicity
EP3167396B1 (en) * 2014-07-11 2024-01-17 Iogenetics, LLC. Immune recognition motifs
JP6730988B2 (ja) 2014-12-03 2020-07-29 プロクララ バイオサイエンシーズ， インコーポレイテッド グリコシル化シグナルを欠く改変バクテリオファージｇ３ｐアミノ酸配列を含むポリペプチド
SE541355C2 (en) 2016-12-22 2019-08-13 Alfa Laval Corp Ab A plate heat exchanger with six ports for three different media

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022653A1 (en) * 1991-06-14 1992-12-23 Genentech, Inc. Method for making humanized antibodies
US6307026B1 (en) * 1992-12-10 2001-10-23 Celltech Limited Humanized antibodies directed against A33 antigen
AU2003285586A1 (en) * 2002-12-03 2004-06-23 Medical Research Council Regulatory t-cells
WO2006082406A2 (en) * 2005-02-03 2006-08-10 Antitope Limited Human antibodies and proteins

Also Published As

Publication number Publication date
KR101485202B1 (ko) 2015-01-22
AU2007306102B2 (en) 2012-02-23
AU2007306102A1 (en) 2008-04-17
EP2080138A2 (en) 2009-07-22
JP5456477B2 (ja) 2014-03-26
SG175596A1 (en) 2011-11-28
WO2008044032A2 (en) 2008-04-17
US20120289417A1 (en) 2012-11-15
JP2010505929A (ja) 2010-02-25
CA2666320A1 (en) 2008-04-17
KR20090069326A (ko) 2009-06-30
US20100017370A1 (en) 2010-01-21
WO2008044032A3 (en) 2009-06-04
RU2009113455A (ru) 2010-11-20

Similar Documents

Publication Publication Date Title
SG10201502661SA (en) T cell epitope databases
GB2424118B (en) Fuel cells
EP2095275A4 (en) SEARCH FOR AN EVENT
EP2156296A4 (en) STORAGE IN CLUSTERS USING UNDER-SEGMENTATION
GB0605878D0 (en) Fuel cells
GB0614338D0 (en) Fuel cells
GB0608079D0 (en) Fuel cells
GB0614337D0 (en) Fuel Cells
EP2035970A4 (en) RESEARCH BASED ON BASKETS
EP1953858A4 (en) FUEL CELL
EP1970988A4 (en) FUEL CELL
EP1976047A4 (en) FUEL CELL
EP1873853A4 (en) FUEL CELL
EP1863112A4 (en) FUEL CELL
EP1953859A4 (en) FUEL CELL
GB0705492D0 (en) Waterwheel
EP1863113A4 (en) FUEL CELL
EP1950827A4 (en) FUEL CELL
EP1930911A4 (de) Amorphisierter kernbrennstoff
EP1873855A4 (en) FUEL CELL
GB0503918D0 (en) Cell
EP1942542A4 (en) FUEL CELL
EP1883128A4 (en) FUEL CELL
EP1865568A4 (en) FUEL CELL
GB0606986D0 (en) Biofuels